Literature DB >> 33057889

Comparison of scoring systems for predicting stone-free status and complications after retrograde ıntrarenal surgery.

Ridvan Ozbek1, Cagri Senocak2, Hakan Bahadir Haberal2, Erman Damar2, Fahri Erkan Sadioglu2, Omer Faruk Bozkurt2.   

Abstract

PURPOSE: To compare the effectiveness of scoring systems in predicting stone-free rates (SFR) and complications following retrograde intrarenal surgery (RIRS).
MATERIALS AND METHODS: We retrospectively analyzed 280 patients who underwent RIRS for kidney stones between 2016 and 2019. The Resorlu-Unsal Stone score (RUSS), Modified Seoul National University Renal Stone Complexity (S-ReSC) score, and R.I.R.S. scoring system score were calculated for each patient who was enrolled in the study. Subsequently, stone scoring systems were compared as to their predictive capability for SFR using receiver-operating characteristic curves. Furthermore, multivariate analysis was done to determine whether the scoring systems associated with SFR and complications.
RESULTS: The median patient age was 44 (35--56). The median RUSS, S-ReSC, and R.I.R.S scores were 0 (0-1), 1(1-2), and 6 (5-7), respectively. The overall SFR was 76.7%. The R.I.R.S. scoring system was found to have a higher predictive value in predicting postoperative SFR than the other two scoring systems (p < 0.001, AUC = 0,816). RUSS, R.I.R.S. score, and stone size were found to be independent predictive factors for SFR (p = 0.049, p = 0.024, p = 0.033, respectively). Complications were observed in 3.2%(9/280) of patients. Stone scoring systems were not statistically associated with complications. Operation duration was the only independent risk factor for complications (p = 0.010).
CONCLUSIONS: The R.I.R.S. scoring system was found to have a higher predictive value than RUSS and S-ReSC to predict SFR following RIRS in our study. However, none of the stone scoring systems was directly proportional to complications of RIRS.
© 2020. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Laser lithotripsy; Renal calculi; Scoring methods; Treatment outcome; Ureteroscopy

Mesh:

Year:  2020        PMID: 33057889     DOI: 10.1007/s00345-020-03478-4

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  3 in total

1.  Risk Factors of Infectious Complications after Flexible Uretero-renoscopy with Laser Lithotripsy.

Authors:  Cagri Senocak; Cihat Ozcan; Tolga Sahin; Gulden Yilmaz; Ekrem Ozyuvali; Selcuk Sarikaya; Berkan Resorlu; Ural Oguz; Omer Faruk Bozkurt; Ali Unsal; Oztug Adsan
Journal:  Urol J       Date:  2018-07-10       Impact factor: 1.510

2.  Risk factors of infectious complications following flexible ureteroscope with a holmium laser: a retrospective study.

Authors:  Song Fan; Binbin Gong; Zongyao Hao; Li Zhang; Jun Zhou; Yifei Zhang; Chaozhao Liang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  Retrograde intrarenal surgery (RIRS) in the treatment of calyceal diverticulum with lithiasis.

Authors:  Jose Luis Palmero; Jaume Miralles; Carmen Garau; Ines Nuño de la Rosa; Araceli Amoros; Antonio Benedicto
Journal:  Arch Esp Urol       Date:  2014-05       Impact factor: 0.436

  3 in total
  3 in total

1.  About "Comparison of scoring systems for predicting stone‑free status and complications after retrograde ıntrarenal surgery".

Authors:  Oktay Özman
Journal:  World J Urol       Date:  2021-08-14       Impact factor: 4.226

Review 2.  Recent scoring systems predicting stone-free status after retrograde intrarenal surgery; a systematic review and meta-analysis.

Authors:  Oktay Özman; Hacı Murat Akgül; Cem Başataç; Eyüp Burak Sancak; Önder Çınar; Hakan Çakır; Cenk Murat Yazıcı; Haluk Akpınar; Bülent Önal
Journal:  Cent European J Urol       Date:  2022-03-24

3.  Computational Analysis of Influencing Factors and Multiple Scoring Systems of Stone Clearance Rate after Flexible Ureteroscopic Lithotripsy.

Authors:  Lei Xia; Hanqing Xuan; Yang Cao; Zhebin Du; Hai Zhong; Qi Chen
Journal:  Comput Intell Neurosci       Date:  2022-09-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.